This enabled us to pinpoint 3 significant common target genes (ETS1, DVL2, and IL1RAP) exhibiting markedly distinct expression profiles in both VAT and SAT among patients with obesity and T2D. This evidence concerns the gene DVL2 and type 2 diabetes mellitus.